Protara Therapeutics Statistics

Total Valuation

TARA has a market cap or net worth of $130.02 million. The enterprise value is -$23.27 million.

Market Cap	130.02M
Enterprise Value	-23.27M

Important Dates

The next estimated earnings date is Tuesday, August 5, 2025, before market open.

Earnings Date	Aug 5, 2025
Ex-Dividend Date	n/a

Share Statistics

TARA has 38.58 million shares outstanding. The number of shares has increased by 145.71% in one year.

Current Share Class	38.58M
Shares Outstanding	38.58M
Shares Change (YoY)	+145.71%
Shares Change (QoQ)	+54.01%
Owned by Insiders (%)	2.59%
Owned by Institutions (%)	67.36%
Float	34.18M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.82
P/TBV Ratio	0.82
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 18.03, with a Debt / Equity ratio of 0.03.

Current Ratio	18.03
Quick Ratio	17.77
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -41.88% and return on invested capital (ROIC) is -28.40%.

Return on Equity (ROE)	-41.88%
Return on Assets (ROA)	-27.16%
Return on Invested Capital (ROIC)	-28.40%
Return on Capital Employed (ROCE)	-31.84%
Revenue Per Employee	n/a
Profits Per Employee	-$1.38M
Employee Count	33
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +26.22% in the last 52 weeks. The beta is 1.36, so TARA's price volatility has been higher than the market average.

Beta (5Y)	1.36
52-Week Price Change	+26.22%
50-Day Moving Average	3.57
200-Day Moving Average	3.50
Relative Strength Index (RSI)	51.11
Average Volume (20 Days)	291,573

Short Selling Information

The latest short interest is 2.25 million, so 5.83% of the outstanding shares have been sold short.

Short Interest	2.25M
Short Previous Month	2.48M
Short % of Shares Out	5.83%
Short % of Float	6.58%
Short Ratio (days to cover)	4.31

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-51.43M
Pretax Income	-40.69M
Net Income	-45.42M
EBITDA	-51.10M
EBIT	-51.43M
Earnings Per Share (EPS)	-$1.63

Full Income Statement

Balance Sheet

The company has $124.36 million in cash and $4.23 million in debt, giving a net cash position of $153.29 million or $3.97 per share.

Cash & Cash Equivalents	124.36M
Total Debt	4.23M
Net Cash	153.29M
Net Cash Per Share	$3.97
Equity (Book Value)	158.48M
Book Value Per Share	4.11
Working Capital	119.51M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$40.14 million and capital expenditures -$107,000, giving a free cash flow of -$40.25 million.

Operating Cash Flow	-40.14M
Capital Expenditures	-107,000
Free Cash Flow	-40.25M
FCF Per Share	-$1.04

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TARA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-145.71%
Shareholder Yield	-145.71%
Earnings Yield	-34.93%
FCF Yield	-30.96%

Analyst Forecast

The average price target for TARA is $20.67, which is 513.35% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$20.67
Price Target Difference	513.35%
Analyst Consensus	Strong Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2